Armata Pharmaceuticals Inc. buy me8
Start price
24.07.23
/
0%
€1.37
Target price
24.07.24
€1.00
Performance (%)
66.42%
End price
26.07.23
€2.28
Summary
This prediction ended on 26.07.23 with a price of €2.28. With a performance of 66.42% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Armata Pharmaceuticals Inc. | 2.000% | 2.000% | -19.048% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to me8 what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Little innovation
Few uniques
Comments by me8 for this prediction
In the thread Armata Pharmaceuticals Inc. diskutieren
Buy Armata Pharmaceuticals Inc.
Kursziel gesetzt auf 1,0
In the thread Trading Armata Pharmaceuticals Inc.
Buy beendet